An Overview

  • The Converge Advisory Group serves as trusted and unbiased advisors by focusing exclusively on helping our clients bring innovative medicines to market faster and with a greater probability of success.

  • We apply a broad and deep understanding of drug development and commercialization, based on 40+ years of combined experience, to help clients improve pipeline productivity throughout the lifecycle with strategic and operational support.

  • We employ a unique and innovative consulting approach that leverages large and un-biased evidence-based strategies and flexible project delivery models.

  • We design higher quality strategies faster than our competition by applying our combined 40+ years of experience, a machine-learning platform, and proven methodologies and tool sets.

Our Leadership

Robert S. Liebman, MBA  Managing Director

Robert co-founded and serves as a Managing Director with the Converge Advisory Group and has more than 20 years of experience driving improved business performance in his clients businesses

Prior to co-founding the Converge Advisory Group, Robert was a Principal and member of the Quintiles Advisory Services leadership team. Previously, he founded the Bedrock Consulting Group, a specialty consulting firm focused on global operations strategy. Robert also held leadership positions with PwC (formerly PRTM) and Archstone Consulting. Robert’s client work includes a full range of engagements across the product lifecycle with a focus on clinical and commercial strategies.

Subha B. Basu, PhD/MBA  Managing Director

Subha co-founded and serves as a Managing Director with the Converge Advisory Group and has over 20 years of academic, industry and consulting experience.

Prior to co-founding the Converge Advisory Group, Subha held senior positions with Decision Resources Group, Quintiles Advisory Services, Frost & Sullivan and Becton Dickinson.

Subha has extensive exposure to opportunity assessment, emerging markets and strategy development in pharma, bioprocessing, medtech and biosimilars sectors.

Contact Form

Your form message has been successfully sent.

You have entered the following data:



Please correct your input in the following fields:
Error while sending the form. Please try again later.

Note: Fields marked with * are required

Print Print | Sitemap
© Converge Advisory Group